MUMBAI: Sputnik V Covid-19 of Russia vaccine, which reported an efficiency of more than 95%, will be twice as cheap as Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya Institute Y RDIF (Russian Direct Investment Fund), will be priced at less than $ 20 per person …
Read More »Sputnik ‘95% Efficacy’, cheaper than American vaccines | India News
